As Trial Nears, Kaiser Flays Pfizer Neurontin Studies
With a trial in the multidistrict litigation over Pfizer Inc.'s alleged off-label marketing of Neurontin just a month away, Kaiser Foundation Health Plan Inc. is attacking the credibility of Pfizer's expert...To view the full article, register now.
Already a subscriber? Click here to view full article